MX2007004247A - Angiopoietin-2 specific binding agents. - Google Patents

Angiopoietin-2 specific binding agents.

Info

Publication number
MX2007004247A
MX2007004247A MX2007004247A MX2007004247A MX2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A
Authority
MX
Mexico
Prior art keywords
angiopoietin
specific binding
binding agents
antibodies
disclosed
Prior art date
Application number
MX2007004247A
Other languages
Spanish (es)
Inventor
Jonathan Daniel Oliner
Kevin Graham
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/982,440 external-priority patent/US7658924B2/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2007004247A publication Critical patent/MX2007004247A/en

Links

Abstract

Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies.
MX2007004247A 2004-10-19 2005-10-19 Angiopoietin-2 specific binding agents. MX2007004247A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62016104P 2004-10-19 2004-10-19
US10/982,440 US7658924B2 (en) 2001-10-11 2004-11-04 Angiopoietin-2 specific binding agents
PCT/US2005/037911 WO2006045049A1 (en) 2004-10-19 2005-10-19 Angiopoietin-2 specific binding agents

Publications (1)

Publication Number Publication Date
MX2007004247A true MX2007004247A (en) 2007-06-12

Family

ID=39608222

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007004247A MX2007004247A (en) 2004-10-19 2005-10-19 Angiopoietin-2 specific binding agents.

Country Status (10)

Country Link
JP (2) JP2008520188A (en)
CN (1) CN101495513B (en)
BR (1) BRPI0518209A (en)
EA (1) EA011866B1 (en)
IL (1) IL182279A0 (en)
MA (1) MA29015B1 (en)
MX (1) MX2007004247A (en)
RU (2) RU2404992C2 (en)
SG (1) SG156668A1 (en)
ZA (1) ZA200704020B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG156668A1 (en) * 2004-10-19 2009-11-26 Amgen Inc Angiopoietin-2 specific binding agents
JO3182B1 (en) * 2009-07-29 2018-03-08 Regeneron Pharma High Affinity Human Antibodies to Human Angiopoietin-2
EA022546B1 (en) * 2011-09-28 2016-01-29 Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук Method for inhibiting growth of ehrlich carcinoma in laboratory animal
KR102225422B1 (en) * 2011-09-30 2021-03-08 다나-파버 캔서 인스티튜트 인크. Therapeutic peptides
BR112014017882A2 (en) * 2012-01-23 2017-06-27 Regeneron Pharma stabilized formulations containing anti-ang-2 antibodies
EP2935294A4 (en) * 2012-12-21 2016-08-31 Univ California Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity
EP2997377B1 (en) 2013-05-14 2018-07-18 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
AR100270A1 (en) * 2014-05-19 2016-09-21 Lilly Co Eli ANTIBODIES ANG2
MX2017001980A (en) 2014-08-28 2017-05-04 Eisai R&D Man Co Ltd High-purity quinoline derivative and method for manufacturing same.
SG11201706630UA (en) 2015-02-25 2017-09-28 Eisai R&D Man Co Ltd Method for suppressing bitterness of quinoline derivative
AU2015384801B2 (en) 2015-03-04 2022-01-06 Eisai R&D Management Co., Ltd. Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
MX2017015896A (en) 2015-06-16 2018-08-09 Eisai R&D Man Co Ltd Anticancer agent.
CN106512006A (en) * 2016-07-25 2017-03-22 广州道瑞医药科技有限公司 Application of ANGPT2 secretion inhibitor to preparation of medicine for treating hemangiomas
CN106075448A (en) * 2016-07-25 2016-11-09 广州道瑞医药科技有限公司 ANGPT2 inhibitor is used for treating the application in angiomatous medicine in preparation
CN109096368B (en) * 2018-09-30 2021-07-20 华南理工大学 Polypeptide with antioxidant and liver protecting activities, gene for encoding polypeptide, preparation method and application thereof
JP7177284B2 (en) * 2019-02-25 2022-11-22 ファームアブシン・インコーポレイテッド Anti-ANG2 antibody and use thereof
CN112126671B (en) * 2020-08-18 2021-08-31 中山大学附属第五医院 Application of streptococcus agalactiae streptococcus agalactiae in treating endometriosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60003011T2 (en) * 1999-03-26 2004-04-08 Regeneron Pharmaceuticals, Inc. MODULATING VASCER PERMABILITY BY TIE2 RECEPTOR ACTIVATORS
US7521053B2 (en) * 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7205275B2 (en) * 2001-10-11 2007-04-17 Amgen Inc. Methods of treatment using specific binding agents of human angiopoietin-2
AU2002362772B2 (en) * 2001-10-12 2007-09-06 Aquestive Therapeutics, Inc. Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
SG156668A1 (en) * 2004-10-19 2009-11-26 Amgen Inc Angiopoietin-2 specific binding agents

Also Published As

Publication number Publication date
EA011866B1 (en) 2009-06-30
RU2404992C2 (en) 2010-11-27
RU2007118670A (en) 2008-12-27
RU2010132956A (en) 2012-02-10
JP2008520188A (en) 2008-06-19
BRPI0518209A (en) 2008-11-04
SG156668A1 (en) 2009-11-26
CN101495513A (en) 2009-07-29
JP2011207882A (en) 2011-10-20
ZA200704020B (en) 2008-06-25
IL182279A0 (en) 2007-07-24
MA29015B1 (en) 2007-11-01
CN101495513B (en) 2014-08-06
EA200700876A1 (en) 2007-10-26

Similar Documents

Publication Publication Date Title
MX2007004247A (en) Angiopoietin-2 specific binding agents.
RS28904A (en) Angiopoietin-2 specific binding agents
MY156458A (en) Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
LUC00025I2 (en)
PH12016501691A1 (en) Antibodies to matrix metalloproteinase 9
SG166090A1 (en) Il-13 binding agents
WO2010017103A3 (en) Fully human anti-human nkg2d monoclonal antibodies
TN2011000528A1 (en) Compositions and methods for antibodies targeting complement protein c3b
WO2012047583A3 (en) Antibodies binding human collagen ii
EA200400526A1 (en) AGENTS SPECIFICALLY CONNECTING WITH HUMAN ANGIOPOETIN-2
MX2009006471A (en) Engineered anti-tslp antibody.
WO2006029220A3 (en) Combination therapy with anti-ctla4 and anti-4-1bb antibodies
WO2006116319A3 (en) Reagents that bind ccx-ckr2
WO2007076465A3 (en) Cln248 antibody compositions and methods of use
TN2010000374A1 (en) Antibodies directed to angiopoietin -1 and angiopoietin-2 and use thereof

Legal Events

Date Code Title Description
FG Grant or registration